Biktarvy® (Bictegravir/Emtricitabine/Tenofovir Alafenamide Tablets): Breaking the Barriers in the Treatment of HIV-1 Infection
In the field of human immunodeficiency virus (HIV) treatment, the development and application of fixed-dose combination therapies have significantly improved treatment convenience and patient adherence. Biktarvy® (generic name: bictegravir/emtricitabine/tenofovir alafenamide tablets) is a well-established triple-drug antiretroviral regimen that, since its approval, has become an important...
0 Comentários 0 Compartilhamentos 107 Visualizações 0 Anterior